Search
moon
sun
๐Ÿ’”

T50. Cardiogenic Shock*

A. Introduction

โ€ข
์ ์ ˆํ•œ circulating volume์—๋„ ๋ถˆ๊ตฌํ•˜๊ณ  ๋ถ€์ ์ ˆํ•œ ์กฐ์ง ์ €๊ด€๋ฅ˜๋ฅผ ์œ ๋ฐœํ•˜๋Š” ๊ธ‰์„ฑ ์‹ฌ๋ฐ•์ถœ๋Ÿ‰ ๊ฐ์†Œ ์ƒํƒœ
โ€ข
AMI ํ™˜์ž์—์„œ ๋ณ‘์› ๋‚ด ์‚ฌ๋ง์˜ ๊ฐ€์žฅ ํ”ํ•œ ์›์ธ.
โ€ข
AMI ํ™˜์ž ์‹ฌ์ธ์„ฑ ์‡ผํฌ์˜ ์น˜๋ฃŒ๋Š” ์žฌ๊ด€๋ฅ˜์š”๋ฒ• (PCI or CABG)์œผ๋กœ, ์•ฝ๋ฌผ ์น˜๋ฃŒ๋งŒ ํ•˜๋Š” ๊ฒƒ๋ณด๋‹ค ํšจ๊ณผ์ 

B. Pathophysiology

B1. ์›์ธ

C. Clinical Features

โ€ข
Hypoperfusion์— ์˜ํ•ด ๋ฐœ์ƒ 1. sBP < 90mmHg, ๊ณ ํ˜ˆ์•• ์žˆ๋Š” ํ™˜์ž์—์„œ๋Š” sBP ๊ฐ€ ๋” ๋†’์„ ์ˆ˜ ์žˆ๋‹ค. 2. ์ „์‹ ํ˜ˆ๊ด€์ €ํ•ญ์ด ๋‚ด๋ ค๊ฐ€์ง€ ์•Š์€ ํ™˜์ž๋ผ๋ฉด pulse pressure < 20mmHg์ธ ์  ๋˜ํ•œ ๊ธฐ์ค€์ด ๋  ์ˆ˜ ์žˆ๋‹ค. 3. Tachypnea, rale, cool skin, diaphoresis, mental change, low urine output ๋“ฑ์ด ์ƒ๊ธธ ์ˆ˜ ์žˆ๋‹ค. 4. ๊ธ‰์„ฑ ์‹ฌ๊ทผ๊ฒฝ์ƒ‰ ์ดํ›„ ์‹ฌ์ธ์„ฑ ์‡ผํฌ ํ™˜์ž์˜ 10%์—์„œ mechanical complication์ด ๋ฐœ์ƒ๋œ๋‹ค.
์ด ๋•Œ new murmur ๊ฐ€ ๋ฐœ์ƒ (1) ๊ธ‰์„ฑ MR์˜ ๊ฒฝ์šฐ chordae tendineae rupture ํ˜น์€ papillary muscle dysfunction์— ์˜ํ•ด ๋ฐœ์ƒ (2) ๊ธ‰์„ฑ ventral septal defect๋Š” new loud holosystolic left parasternal murmur์™€ ์—ฐ๊ด€ (3) ๊ธ‰์„ฑ aortic insufficiency์˜ ๊ฒฝ์šฐ soft diastolic murmur ๋ฐ softer S1 sound๊ฐ€ ๋“ค๋ฆฌ๋Š” ๊ฒƒ์ด ํŠน์ง•

D. Diagnosis

D1. ์‹ ์ฒด๊ฒ€์‚ฌ

โ€ข
Rale, ๊ฒฝ์ •๋งฅ ํŒฝ๋Œ€, Hepatohugular reflex, edmea, murmurs

D2. ECG

โ€ข
R/O STEMI
โ€ข
Ischemic change ํ™•์ธ

D3. Echocardiography (์‡ผํฌ ์ดˆ์ŒํŒŒ ๋ถ€๋ถ„ ์ฐธ์กฐ)

โ€ข
EF, RWMA, Dilated RV, Pericardial Fluid, Valvular dysfunction, Aortic root < 3cm, IVC (volume), B-line
1 IVC ์ธก์ • โ†’ Volume status ๋ฐ ์šฐ์‹ฌ๋ฐฉ ์••๋ ฅ ์ธก์ • 2 Cardiac tamponade โ†’ Pericardial effusion ๋ฐ IVC ํ™•์žฅ, RV์˜ ์ด์™„๊ธฐ collapse
RA์˜ ์ˆ˜์ถ•๊ธฐ collapse 3 Cardiac rupture : Pericardial space์— visible clot ๊ด€์ฐฐ๋จ.
4 ๋Œ€๋™๋งฅ ๋ฐ•๋ฆฌ : Aortic root 3cm ์ดˆ๊ณผ ์‹œ ์˜์‹ฌ.
5 ์šฐ์‹ฌ์‹ค ๋ถ€์ „ : ์šฐ์‹ฌ์‹ค size > ์ขŒ์‹ฌ์‹ค size

D4. Lab test

(1) Troponin ์™€ ๊ฐ™์€ biomarker๋Š” ์ดˆ๊ธฐ์— ์˜ค๋ฅด์ง€ ์•Š์„ ์ˆ˜๋„ ์žˆ์Œ

(2) ํ˜ˆ์ฒญ BNP ์ˆ˜์น˜

โ€ข
LV dysfunction์˜ indicator์ด๋ฉฐ, ์Œ์„ฑ ์˜ˆ์ธก๋„๊ฐ€ ๋†’๋‹ค.
โ€ข
์ด๋Š” ๊ทน์ดˆ๊ธฐ์ธ ๊ฒฝ์šฐ ํ˜น์€ ๋‹จ๋… ์šฐ์‹ฌ์‹ค ๋ถ€์ „์ด ์•„๋‹ˆ๋ผ๋ฉด normal BNP๋Š” cardiogenic shock์ด ์•„๋‹ˆ๋ผ๋Š” ๊ฒƒ์„ ์˜๋ฏธํ•œ๋‹ค.

E. Treatment

E1. ์‘๊ธ‰ revascularization(PCI, CABG) : TOC

E2. Airway ์œ ์ง€ : Saturation 91% ์ด์ƒ ์œ ์ง€๋˜๊ฒŒ

E3. Stabilization

โ€ข
Aspirin๋Š” ์ดˆ๊ธฐ์— ํˆฌ์—ฌ (CIx. ์•„๋‹ ์‹œ)
โ€ข
ฮฑ-blocker๋Š” ๊ธˆ๊ธฐ?? (Text ์˜คํƒ€ ์•„๋‹Œ๊ฐ€โ€ฆ.beta blocker ์ผ ๋“ฏ)

E4. Hypotension

(1) ํ์šธํ˜ˆ์ด ์—†์œผ๋ฉด : Fluid

(2) ํ์šธํ˜ˆ์ด ์žˆ์œผ๋ฉด Vasopression or Inotropes

โ€ข
SBP 90 ์ด์ƒ์ด๋ฉด dobutamine ์‚ฌ์šฉ
โ€ข
SBP 70 ์ดํ•˜์‹œ์—๋Š” dobutamine ๋ณด๋‹ค๋Š” norepinephrine ์‚ฌ์šฉ
โ€ข
Vasoconstrictor์™€ dobutamine์„ ๊ฐ™์ด ์‚ฌ์šฉํ•˜๋Š”๊ฒŒ ๋„์›€

E5. ํ˜ˆ์ „์šฉํ•ด์ œ

โ€ข
์‘๊ธ‰ coronary intervention๋งŒํผ์˜ ํšจ๊ณผ๋Š” ์—†๋‹ค.

E6. IABP, percutaneous LV assist devices, ECMO

VI. Disposition - 9ํŒ์—์„œ ์‚ญ์ œ๋จ
1. ์‹ฌ์ธ์„ฑ ์‡ผํฌ ํ™˜์ž๋Š” ๋ชจ๋‘ ์นจ์Šต์ ์ธ revascularization ์‹œ์„ค์ด ๊ฐ–์ถ”์–ด์ง„ ICU๋กœ ์ž…์›. 2. ์‹œ์„ค์ด ๊ฐ–์ถ”์–ด์ง€์ง€ ์•Š์€ ๊ฒฝ์šฐ ๊ฐ€๋Šฅํ•œ ํ•œ ๋นจ๋ฆฌ ์‹œ์„ค์ด ๊ฐ–์ถ”์–ด์ง„ ์ƒ๊ธ‰๋ณ‘์›์œผ๋กœ ์ „์›. 3. ์ „์› ์‹œ ์‹œ๊ฐ„์ด ์˜ค๋ž˜ ๊ฑธ๋ฆฌ๊ฑฐ๋‚˜ ์‚ฌ์ •์ด ์—ฌ์˜์น˜ ์•Š์„ ๋•Œ๋Š” ํ˜ˆ์ „์šฉํ•ด์ œ ์น˜๋ฃŒ๋ฅผ ์‚ฌ์šฉํ•œ๋‹ค.